TandemAI
About:
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
Website: https://www.tandemai.com/
Top Investors: OrbiMed, Qiming Venture Partners, F-Prime Capital, Eight Roads Ventures, Chengwei Capital
Description:
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
Total Funding Amount:
$65.5M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2021-01-01
Founders:
Jeff He
Number of Employees:
101-250
Last Funding Date:
2024-08-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai